Component
IND02 C. zeylanicum polyphenol-rich nasal spray
IND02 C. zeylanicum polyphenol-rich nasal spray. Species, exposure and limitations are retained in each linked claim.
2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
IND02 nasal spray improved the rhinoconjunctivitis quality-of-life score compared with placebo after seven days.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/ceylon-research/31780001.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9dec4d6fda0520bf0d9fb8adf77c76254bfc44c05308367b8486a39d8d8611b2", "start_char": 0, "end_char": 1863, "text_sha256": "9dec4d6fda0520bf0d9fb8adf77c76254bfc44c05308367b8486a39d8d8611b2"}
- experimental_model
- Randomized double-blind placebo-controlled nasal-spray trial
- exposure
- IND02 100 micrograms/100 microliters in each nostril twice daily for seven days
- limitations
- Intranasal formulated extract, not eating cinnamon, inhaling powder or using essential oil. Short follow-up and formulation-specific outcomes.
- nutrient_topic
- Ceylon cinnamon research collection; topical membership is not evidence of a direct dietary effect. · Ceylon cinnamon / Cinnamomum verum bark preparations
- organism
- Human
- plain_language
- The tested nasal formulation improved this allergy outcome; the route and preparation are part of the result.
- primary_references
- [ceylon-p31780001] A randomized, double-blind placebo-controlled study of intranasal standardized cinnamon bark extract for seasonal allergic rhinitis. (2019). https://pubmed.ncbi.nlm.nih.gov/31780001/ DOI: 10.1016/j.ctim.2019.102198
- tissue_or_cell_type
- Adults 18–75 with seasonal allergic rhinitis
Ceylon cinnamon: metabolism, signaling and nutrient connections (2026-09-17) · lines 1260–1271
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized double-blind placebo-controlled nasal-spray trial · source_derived_draft · unverified_draft
### ceylon-nasal-rqlq IND02 nasal spray improved the rhinoconjunctivitis quality-of-life score compared with placebo after seven days. Condition category: normal nutrient_topic: Ceylon cinnamon research collection; topical membership is not evidence of a direct dietary effect. plain_language: The tested nasal formulation improved this allergy outcome; the route and preparation are part of the result. organism: Human tissue_or_cell_type: Adults 18–75 with seasonal allergic rhinitis experimental_model: Randomized double-blind placebo-controlled nasal-spray trial limitations: Intranasal formulated extract, not eating cinnamon, inhaling powder or using essential oil. Short follow-up and formulation-specific outcomes. exposure: IND02 100 micrograms/100 microliters in each nostril twice daily for seven days evidence_span: {"source_cache": "artifacts/ceylon-research/31780001.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9dec4d6fda0520bf0d9fb8adf77c76254bfc44c05308367b8486a39d8d8611b2", "start_char": 0, "end_char": 1863, "text_sha256": "9dec4d6fda0520bf0d9fb8adf77c76254bfc44c05308367b8486a39d8d8611b2"} [ceylon-p31780001] A randomized, double-blind placebo-controlled study of intranasal standardized cinnamon bark extract for seasonal allergic rhinitis. (2019). https://pubmed.ncbi.nlm.nih.gov/31780001/ DOI: 10.1016/j.ctim.2019.102198
Complete structured claim and evidenceIND02 nasal spray improved the total daily rhinitis symptom score compared with placebo after seven days.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/ceylon-research/31780001.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9dec4d6fda0520bf0d9fb8adf77c76254bfc44c05308367b8486a39d8d8611b2", "start_char": 0, "end_char": 1863, "text_sha256": "9dec4d6fda0520bf0d9fb8adf77c76254bfc44c05308367b8486a39d8d8611b2"}
- experimental_model
- Randomized double-blind placebo-controlled nasal-spray trial
- exposure
- IND02 100 micrograms/100 microliters in each nostril twice daily for seven days
- limitations
- Intranasal formulated extract, not eating cinnamon, inhaling powder or using essential oil. Short follow-up and formulation-specific outcomes.
- nutrient_topic
- Ceylon cinnamon research collection; topical membership is not evidence of a direct dietary effect. · Ceylon cinnamon / Cinnamomum verum bark preparations
- organism
- Human
- plain_language
- The tested nasal formulation improved this allergy outcome; the route and preparation are part of the result.
- primary_references
- [ceylon-p31780001] A randomized, double-blind placebo-controlled study of intranasal standardized cinnamon bark extract for seasonal allergic rhinitis. (2019). https://pubmed.ncbi.nlm.nih.gov/31780001/ DOI: 10.1016/j.ctim.2019.102198
- tissue_or_cell_type
- Adults 18–75 with seasonal allergic rhinitis
Ceylon cinnamon: metabolism, signaling and nutrient connections (2026-09-17) · lines 1273–1284
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized double-blind placebo-controlled nasal-spray trial · source_derived_draft · unverified_draft
### ceylon-nasal-symptoms IND02 nasal spray improved the total daily rhinitis symptom score compared with placebo after seven days. Condition category: normal nutrient_topic: Ceylon cinnamon research collection; topical membership is not evidence of a direct dietary effect. plain_language: The tested nasal formulation improved this allergy outcome; the route and preparation are part of the result. organism: Human tissue_or_cell_type: Adults 18–75 with seasonal allergic rhinitis experimental_model: Randomized double-blind placebo-controlled nasal-spray trial limitations: Intranasal formulated extract, not eating cinnamon, inhaling powder or using essential oil. Short follow-up and formulation-specific outcomes. exposure: IND02 100 micrograms/100 microliters in each nostril twice daily for seven days evidence_span: {"source_cache": "artifacts/ceylon-research/31780001.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9dec4d6fda0520bf0d9fb8adf77c76254bfc44c05308367b8486a39d8d8611b2", "start_char": 0, "end_char": 1863, "text_sha256": "9dec4d6fda0520bf0d9fb8adf77c76254bfc44c05308367b8486a39d8d8611b2"} [ceylon-p31780001] A randomized, double-blind placebo-controlled study of intranasal standardized cinnamon bark extract for seasonal allergic rhinitis. (2019). https://pubmed.ncbi.nlm.nih.gov/31780001/ DOI: 10.1016/j.ctim.2019.102198
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.